Tabuk Fexodine 180mg is an oral antihistamine containing fexofenadine hydrochloride as its active pharmaceutical ingredient. It is intended to assist with the management of histamine-related allergy symptoms, particularly itching and raised skin welts associated with chronic idiopathic urticaria. The film-coated tablet formulation provides a measured strength of the active ingredient in each individual tablet.
Follow the dosage instructions provided in the approved patient information leaflet or by a healthcare professional. The 180mg strength is generally administered once daily to adults and adolescents aged 12 years and older when appropriate for the relevant indication. Tablets should be swallowed with water rather than fruit juice, as certain juices can affect absorption. Aluminium or magnesium-containing antacids should be separated from administration by approximately two hours. Do not exceed the recommended dose. Professional advice is important for individuals with kidney problems, during pregnancy or breastfeeding, and when taking other medicines. Although fexofenadine is generally less sedating, drowsiness can occur. Store at a temperature not exceeding 30°C and keep out of reach of children.
Tabuk Fexodine 180mg contains an antihistamine that acts on peripheral histamine H1 receptors. Histamine is a naturally occurring substance involved in allergic responses and associated symptoms such as itching and raised skin welts. By limiting histamine activity at these receptors, fexofenadine may help reduce associated discomfort. Its mechanism differs from medicines that directly suppress inflammation through corticosteroid activity.
Each tablet contains fexofenadine hydrochloride 180mg as the active pharmaceutical ingredient. The tablet also incorporates inactive pharmaceutical excipients and film-coating components. The complete list of inactive ingredients and relevant hypersensitivity information should be reviewed in the accompanying patient information leaflet.
The oral formulation provides a defined antihistamine strength for appropriate allergy symptom management under established medical guidance.
Manufactured in Saudi Arabia by Tabuk Pharmaceutical Manufacturing Company. This Fexodine presentation contains 14 oral tablets, each providing 180mg of fexofenadine hydrochloride, as identified in the Saudi Food and Drug Authority registration record. It is available at Pharmacy Plus Kuwait.